Tag: Covid19

Pharma / Biotech

Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19.

Newsemia
Related Articles Pharmacokinetics of Favipiravir in Critically Ill Patients with COVID-19. Clin Transl Sci. 2020 May 31;: Authors: Irie K, Nakagawa A, Fujita H, Tamura...
Latest News

La FDA délivre une autorisation d’utilisation d’urgence de l’Impella RP comme thérapie pour les patients atteints d’insuffisance cardiaque droite dans le contexte de la COVID-19

Newsemia
DANSEURS, Massachusetts–(BUSINESS WIRE)–La Food and Drug Administration (FDA) des États-Unis a délivré une autorisation d’utilisation d’urgence (EUA) pour Impella RP afin d’inclure les patients souffrant...
Latest News

AbCellera’s Rapid Pandemic Response Platform Contributes to the World’s First COVID-19 Clinical Trial for a Potential Monoclonal Antibody Treatment

Newsemia
VANCOUVER, British Columbia–(BUSINESS WIRE)– #AbCellera–LY-CoV555, the lead antibody from the AbCellera and Lilly collaboration, has entered into human testing for the potential treatment of COVID-19....
Neurology

How COVID-19 affects the nervous system

Newsemia
A new paper published in the journal JAMA Neurology in May 2020 discusses the presentation and complications of COVID-19 with respect to the nervous system....
Pharma / Biotech

Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system.

Newsemia
Related Articles Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system. Pharmacol Res. 2020...
Latest News

Celltrion: Positive präklinische Ergebnisse zeigen verbesserte Genesungszeit für antivirale Antikörperbehandlung gegen COVID-19

Newsemia
INCHEON, Südkorea–(BUSINESS WIRE)–Die Celltrion Group gab heute positive präklinische Ergebnisse für ihre antivirale COVID-19-Antikörperbehandlung bekannt, die eine 100-fache Reduzierung der SARS-CoV-2-Viruslast nachweisen. SARS-CoV-2 ist der...
Pharma / Biotech

Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.

Newsemia
Related Articles Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020 May 30;: Authors: Stebbing J, Krishnan V, de Bono...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy